New guidelines and the continuous modification of current policies will be needed in order to establish and maintain an appropriate professional relationship between physicians and pharmaceutical companies.
Research findings indicate that an endocrinologist's treatment of patients hospitalized with diabetic ketoacidosis is more cost-effective than general physicians' treatment of those patients due to greater experience in specialized treatment.